about
Helicobacter pylori and colorectal neoplasia: Is there a causal link?Phenotypic and genetic characterization of antimicrobial profiles of Helicobacter pylori strains in CubaTreatment of Helicobacter pylori infection: Past, present and futureMulticenter Study of Antibiotic Resistance Profile of H. pylori and Distribution of CYP2C19 Gene Polymorphism in Rural Population of Chongqing, ChinaHelicobacter pylori: prevalence and relationship with abdominal pain in school children in Makkah City, western Saudi ArabiaEfflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance.Current options for the treatment of Helicobacter pylori.Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era.Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy.Variation in the use of H. pylori tests in UK general practice--a qualitative study.Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.Helicobacter pylori treatment: antibiotics or probiotics.Human Lysozyme Synergistically Enhances Bactericidal Dynamics and Lowers the Resistant Mutant Prevention Concentration for Metronidazole to Helicobacter pylori by Increasing Cell Permeability.Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicen
P2860
Q26774668-71C1078C-D122-47FD-96F0-F550E47607FDQ34307624-C395425F-B13E-4B4C-8078-0FEEEBD7D3B8Q34508830-D0BD54B8-812E-4A08-B6B2-F45652F26569Q36924777-9AAA38F5-2C56-410D-83D8-03CC083A0DA5Q37243674-B33C4AB8-5F02-4B29-A7FA-83D318F1FCC9Q37346953-349B525F-47FA-4F85-BFB0-E331C92BB8BAQ38075061-DD2E10AB-D8E0-4924-8D50-71BC89C17878Q38238745-12C51830-E801-4ADC-BAEB-58AAB7BFCC29Q38578674-D2362ACF-FA2D-4163-9860-D0D397923D02Q39588933-48A3EDB0-AD37-474F-A49B-9F2E9E4C8FEAQ46539040-6E26DAA4-8E57-48E5-B5F9-EBB5FA35C3F1Q46639990-360F65C2-44D8-4C8F-A688-EA31327D08F8Q48118540-9FF103DB-C2EC-493C-B7B0-C7D52B99D001Q48948199-28A68761-9BB2-4E41-91F1-6D5B45F9CFF3Q58700546-6518A5B1-DF5B-45D8-A97F-F627052DBA0A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Helicobacter pylori public health implications.
@ast
Helicobacter pylori public health implications.
@en
type
label
Helicobacter pylori public health implications.
@ast
Helicobacter pylori public health implications.
@en
prefLabel
Helicobacter pylori public health implications.
@ast
Helicobacter pylori public health implications.
@en
P2860
P1433
P1476
Helicobacter pylori public health implications.
@en
P2093
Richard H Hunt
P2860
P356
10.1111/J.1083-4389.2004.00250.X
P478
P577
2004-01-01T00:00:00Z